ABSTRACT
The liver is a prime site of hematogenous metastases. Metastatic disease accounts for over 95% of all liver tumors (1,2). Due to high blood flow and unique anatomic location, the liver acts as major repository for cancer cells, particularly of gastrointestinal origin (3). Historically, most patients with liver metastases were considered incurable and not offered surgical interventions (4). However, considerable data have accumulated over the last two decades that have proved surgical treatment for hepatic colorectal metastases to be rational and potentially curative.
